Retatrutide 5mg
5mg/vial · 10 vials per kit
$54.00
/ kit€540.00 per vial · Free shipping over €150
Retatrutide is a novel triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. It is currently under active Phase 3 clinical investigation for metabolic research applications.
This compound represents a significant advancement in multi-receptor peptide research, offering investigators a tool to study the interplay between incretin and glucagon signalling pathways in preclinical and translational models.
Each vial contains 5mg of lyophilized Retatrutide with verified purity ≥98.5% by HPLC analysis. Supplied as a kit of 10 vials.
This product is intended for laboratory research purposes only. Not for human consumption, veterinary use, or diagnostic procedures. Purchaser must be 18 years or older.